Mehul Joshi - Mar 3, 2025 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
Chief Financial Officer & PAO
Signature
/s/ David Aaron Lehman, Attorney-in-Fact
Stock symbol
LUNG
Transactions as of
Mar 3, 2025
Transactions value $
-$102,414
Form type
4
Date filed
3/5/2025, 06:12 PM
Previous filing
May 7, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$102K -14.4K -11.21% $7.12 114K Mar 3, 2025 Direct F1, F2
transaction LUNG Common Stock Award $0 +108K +94.75% $0.00 222K Mar 3, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on May 6, 2024.
F2 Includes 2,500 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on February 21, 2025.
F3 Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 3, 2025.